Keywords
Affiliated Institutions
Related Publications
Pharmacotherapy for Nonalcoholic Fatty Liver Disease
Lifestyle modifications and optimization of the management of cardiometabolic comorbidities are currently the mainstay of treatment for patients with nonalcoholic fatty liver di...
Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits
Omega-3 polyunsaturated fatty acids (PUFAs) include α-linolenic acid (ALA; 18:3 ω-3), stearidonic acid (SDA; 18:4 ω-3), eicosapentaenoic acid (EPA; 20:5 ω-3), docosapentaenoic a...
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liv...
Update on Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease is now recognized as the most common liver disease in the United States, with a prevalence of approximately 5% in the general population and up ...
Targeting fatty acid metabolism to improve glucose metabolism
Summary Disturbances in fatty acid metabolism in adipose tissue, liver, skeletal muscle, gut and pancreas play an important role in the development of insulin resistance, impair...
Publication Info
- Year
- 1982
- Type
- review
- Volume
- 3
- Issue
- 4-5
- Pages
- 295-309
- Citations
- 76
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1016/0143-4160(82)90018-5